Clinical utility of FDG-PET and PET/CT in non-malignant thoracic disorders

Molecular Imaging and Biology

Volumn 13, Issue 6, 2011, Pages 1051-1060

  Basu, Sandip ^a   Saboury, Babak ^b   Werner, Tom ^b   Alavi, Abass ^b  

^a TATA MEMORIAL HOSPITAL   (India)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

FDG; Non malignant thoracic disorders; PET; PET CT; Sarcoidosis; Tuberculosis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METHIONINE C 11; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ATHEROSCLEROSIS; CARDIAC SARCOIDOSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; GRAFT RECIPIENT; HUMAN; INTERMETHOD COMPARISON; LUNG SARCOIDOSIS; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MEDIASTINUM CANCER; MEDIASTINUM LYMPH NODE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCUPATIONAL DISEASE; OUTCOME ASSESSMENT; PNEUMOCONIOSIS; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIOISOTOPE DIAGNOSIS; REVIEW; SARCOIDOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX DISEASE; TUBERCULOSIS; VASCULITIS;

DRUG MONITORING; FLUORODEOXYGLUCOSE F18; HUMANS; INFLAMMATION; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; THORACIC DISEASES;

BACTERIA (MICROORGANISMS);

EID: 84855658249     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-010-0459-x     Document Type: Review

References (59)

1. Karam M, Roberts-Klein S, Shet N, Chang J, Feustel P (2008) Bilateral hilar foci on 18F-FDG PET scan in patients without lung cancer: Variables associated with benign and malignant etiology. J Nucl Med 49 (9):1429-1436
2. Bataille L, Lonneux M, Weynand B, Schoonbroodt D, Collard P, Deprez PH (2008) EUS-FNA and FDG-PET are complementary procedures in the diagnosis of enlarged mediastinal lymph nodes. Acta Gastroenterol Belg 71(2):219-229 (Pubitemid 351976345)
3. Sochocky S (1958) Tuberculoma of the lung. Am Rev Tuberc 78 (3):403-410
4. Palmer PE (1979) Pulmonary tuberculosis-usual and unusual radiographic presentations. Semin Roentgenol 14(3):204-243 (Pubitemid 9230443)
5. Braun JJ, Kessler R, Constantinesco A, Imperiale A (2008) (18)F-FDG PET/CT in sarcoidosis management: Review and report of 20 cases. Eur J Nucl Med Mol Imaging 35(8):1537-1543, Epub 2008 Apr 17
6. Silverman KJ, Hutchins GM, Bulkley BH (1978) Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58:1204-1211 (Pubitemid 9092005)
7. Pandya C, Brunken RC, Tchou P, Schoenhagen P, Culver DA (2007) Detecting cardiac involvement in sarcoidosis: A call for prospective studies of newer imaging techniques. Eur Respir J 29(2):418-422 (Pubitemid 46231921)
8. Hyodo E, Hozumi T, Takemoto Y et al (2004) Early detection of cardiac involvement in patients with sarcoidosis by a non-invasive method with ultrasonic tissue characterisation. Heart 90:1275-1280 (Pubitemid 39433985)
9. Kaminaga T, Takeshita T, Yamauchi T, Kawamura H, Yasuda M (2004) The role of iodine-123-labeled 15-(p-iodophenyl)-3R, S-methylpentadecanoic acid scintigraphy in the detection of local myocardial involvement of sarcoidosis. Int J Cardiol 94:99-103 (Pubitemid 38314695)
10. Yamagishi H, Shirai N, Takagi M et al (2003) Identification of cardiac sarcoidosis with 13N-NH3/18F-FDG PET. J Nucl Med 44:1030-1036
11. Okumura W, Iwasaki T, Toyama T, Iso T, Arai M, Oriuchi N, Endo K, Yokoyama T, Suzuki T, Kurabayashi M (2004) Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 45 (12):1989-1998 (Pubitemid 47611626)
12. Ishimaru S, Tsujino I, Takei T, Tsukamoto E, Sakaue S, Kamigaki M, Ito N, Ohira H, Ikeda D, Tamaki N, Nishimura M (2005) Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 26(15):1538-1543, Epub 2005 Apr 4 (Pubitemid 41373496)
13. Alavi A, Gupta N, Alberini JL, Hickeson M, Adam LE, Bhargava P, Zhuang H (2002) Positron emission tomography imaging in nonmalignant thoracic disorders. Semin Nucl Med 32(4):293-321 (Pubitemid 35332975)
14. Basu S, Alavi A (2007) Avid FDG uptake in the right ventricle coupled with enhanced intercostal muscle hypermetabolism in pneumoconiosis. Clin Nucl Med 32(5):407-408 (Pubitemid 46659183)
15. Basu S, Alzeair S, Li G, Dadparvar S, Alavi A (2007) Etiopathologies associated with intercostal muscle hypermetabolism and prominent right ventricle visualization on 2-deoxy-2[F-18]fluoro-Dglucose- positron emission tomography: Significance of an incidental finding and in the setting of a known pulmonary disease. Mol Imaging Biol 9(6):333-339
16. Shukuya T, Naka G, Kawana A, Sugiyama H, Kobayashi N, Kudo K, Yago Y, Tamegai Y, Kubota K (2006) Pneumoconiosis associated with an esophageal ulcer and uptake revealed in FDGPET. Intern Med 45 (5):293-296, Epub 2006 Apr 3
17. Bandoh S, Fujita J, Yamamoto Y, Nishiyama Y, Ueda Y, Tojo Y, Ishii T, Kubo A, Ishida T (2003) A case of lung cancer associated with pneumoconiosis diagnosed by fluorine-18 fluorodeoxyglucose positron emission tomography. Ann Nucl Med 17(7):597-600 (Pubitemid 37433045)
18. Williams HT, Solis V, Dillard TA, Gossage JR Jr, Freant LJ (2008) Malignancy in kaolin pneumoconiosis found with F-18 FDG positron emission tomography. Clin Nucl Med 33(1):4-7
19. Kanegae K, Nakano I, Kimura K, Kaji H, Kuge Y, Shiga T, Zhao S, Okamoto S, Tamaki N (2007) Comparison of MET-PET and FDG- PET for differentiation between benign lesions and lung cancer in pneumoconiosis. Ann Nucl Med 21(6):331-337, Epub 2007 Aug 27 (Pubitemid 47283261)
20. O'Connell M, Kennedy M (2004) Progressive massive fibrosis secondary to pulmonary silicosis appearance on F-18 fluorodeoxyglucose PET/CT. Clin Nucl Med 29(11):754-755 (Pubitemid 39410836)
21. Melloni B, Monteil J, Vincent F, Bertin F, Gaillard S, Ducloux T, Verbeke S, Maubon A, Vandroux JC, Bonnaud F (2004) Assessment of 18F-fluorodeoxyglucose dual-head gamma camera in asbestos lung diseases. Eur Respir J 24(5):814-821 (Pubitemid 39504437)
22. GerbaudoVH, SugarbakerDJ, Britz-CunninghamS,Di CarliMF, Mauceri C, Treves ST (2002) Assessment of malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: Comparison with histopathology. J Nucl Med 43(9):1144-1149 (Pubitemid 34988759)
23. Mavi A, Basu S, Cermik TF, Urhan M, Bathaii M, Thiruvenkatasamy D, Houseni M, Dadparvar S, Alavi A (2009) Potential of dual time point FDG-PET imaging in differentiating malignant from benign pleural disease. Mol Imaging Biol 11(5):369-378
24. Marom EM, McAdams HP, Butnor KJ, Coleman RE (2004) Positron emission tomography with fluoro-2-deoxy-d-glucose (FDG-PET) in the staging of post transplant lymphoproliferative disorder in lung transplant recipients. J Thorac Imaging 19(2):74-78 (Pubitemid 38508834)
25. Bakheet SM, Powe J (1998) Benign causes of 18-FDG uptake on whole body imaging. Semin Nucl Med 28:352-358 (Pubitemid 28478048)
26. Lorenzen J, Buchert R, Bleckmann C, Munchow N, Bohuslavizki KH (1999) A search for the focus in patients with fever of unknown origin: Is positron-emission tomography with F-18-fluorodeoxyglucose helpful? Rofo Fortschr Geb Rontgenstrahlen Neuen Bildgeb Verfahr 171:49-53
27. Watanabe S, Nakamura Y, Kariatsumari K, Nagata T, Sakata R, Zinnouchi S et al (2003) Pulmonary paragonimiasis mimicking lung cancer on FDG-PET imaging. Anticancer Res 23:3437-3440 (Pubitemid 36975446)
28. Lin P, Chu J, Pocock N (2000) Fluorine-18 FDG dual-head gamma camera coincidence imaging of radiation pneumonitis. Clin Nucl Med 25:866-869
29. Hara M, Iida A, Tohyama J, Miura N, Shiraki N, Itoh M et al (2001) FDG-PET findings in sclerosing hemangioma of the lung: A case report. Radiat Med 19:215-218 (Pubitemid 32847581)
30. Yun M, Yeh D, Araujo LI et al (2001) F-18 FDG uptake in the large arteries: A new observation. Clin Nucl Med 26(4):314-319 (Pubitemid 32226294)
31. Yun M, Jang S, Cucchiara A et al (2002) 18F FDG uptake in the large arteries: A correlation study with the atherogenic risk factors. Semin Nucl Med 32(1):70-76 (Pubitemid 34112944)
32. Bural GG, Torigian DA, Chamroonrat W, Alkhawaldeh K, Houseni M, El-Haddad G, Alavi A (2006) Quantitative assessment of the atherosclerotic burden of the aorta by combined FDG-PET and CT image analysis: A new concept. Nucl Med Biol 33(8):1037-1043, Epub 2006 Oct 4 (Pubitemid 44791952)
33. Bural GG, Torigian DA, Chamroonrat W, Houseni M, Chen W, Basu S, Kumar R, Alavi A (2008) FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging 35(3):562-569 (Pubitemid 351674338)
34. Walter MA, Melzer RA, Schindler C, Muller-Brand J, Tyndall A, Nitzsche EU (2005) The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 32:674-681 (Pubitemid 40897490)
35. Blockmans D, De CL, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H (2006) Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: A prospective study of 35 patients. Arthritis Rheum 55:131-137 (Pubitemid 43235138)
36. Hautzel H, Sander O, Heinzel A, Schneider M, Müller HW (2008) Assessment of large-vessel involvement in giant cell arteritis with 18FFDG PET: Introducing an ROC-analysis-based cutoff ratio. J Nucl Med 49(7):1107-1113, Epub 2008 Jun 13 (Pubitemid 351948019)
37. Meller J, Strutz F, Siefker J et al (2003) Early diagnosis and follow-up of aortitis with F-18 FDG PET and MRI. Eur J Nucl Med Mol Imaging 30:730-736 (Pubitemid 36612957)
38. Webb M, Chambers A, Al-Nahhas A et al (2004) The role of F-18-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging 31:627-634 (Pubitemid 38647900)
39. Hara M, Goodman PC, Leder RA (1999) FDG-PET finding in earlyphase Takayasu arteritis. J Comput Assist Tomogr 23:16-18, Full Text via CrossRef (Pubitemid 29095460)
40. Dumarey N, Tang BN, Goldman S, Wautrecht JC, Matos C, Unger P, Nortier J (2007) Papillary muscle inflammation in Takayasu's arteritis revealed by FDG-PET. Eur Heart J 28(8):1011 (Pubitemid 47343889)
41. Blockmans D, Maes A, Stroobants S et al (1999) New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford) 38:444-447 (Pubitemid 29507129)
42. Moosig F, Czech N, Mehl C et al (2004) Correlation between 18- fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: A quantitative PET study. Ann Rheum Dis 63:870-873 (Pubitemid 38850463)
43. Wildhagen K, Meyer GJ, Stoppe G, Heintz P, Deicher H, Hundeshagen H (1989) PET and MR imaging in a neuro-Behçet syndrome. Eur J Nucl Med 15(11):764-766
44. Mineura K, Sasajima T, Kowada M, Shishido F, Uemura K, Nagata K (1989) Sequential PET studies in neuro-Behçet's syndrome. J Neurol 236(6):367-370 (Pubitemid 19211326)
45. Terada T (1991) Magnetic resonance imaging in neuro-Behçet's disease-comparison with clinical, X-ray CT, and PET findings. Ryumachi 31(2):175-183
46. Otte A, Weiner SM, Hoegerle S, Wolf R, Juengling FD, Peter HH, Nitzsche EU (1998) Neuropsychiatric systemic lupus erythematosus before and after immunosuppressive treatment: A FDG PET study. Lupus 7(1):57-59 (Pubitemid 28052665)
47. Weiner SM, Otte A, Schumacher M, Klein R, Gutfleisch J, Brink I, Otto P, Nitzsche EU, Moser E, Peter HH (2000) Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: Value of F-18fluorodeoxyglucose PET. Ann Rheum Dis 59(5):377-385 (Pubitemid 30316785)
48. Stoppe G, Wildhagen K, Meyer GJ, Schober O (1989) Use of fluorodeoxyglucose PET in the diagnosis of central nervous system lupus erythematosus and a comparison with CT and MRI. Nuklearmediziner 28(5):187-192 (Pubitemid 19263444)
49. Meyer GJ, Schober O, Stoppe G, Wildhagen K, Seidel JW, Hundeshagen H (1989) Cerebral involvement in systemic lupus erythematosus (SLE): Comparison of positron emission tomography (PET) with other imaging methods. Psychiatry Res 29(3):367-368 (Pubitemid 19265395)
50. Wildhagen K, Stoppe G, Meyer GJ, Heintz P, Hundeshagen H, Deicher H (1989) Imaging diagnosis of central nervous system involvement in panarteritis nodosa. Z Rheumatol 48(6):323-325 (Pubitemid 20071204)
51. Park IN, Ryu JS, Shim TS (2008) Evaluation of therapeutic response of tuberculoma using F-18 FDG positron emission tomography. Clin Nucl Med 33(1):1-3
52. Chamilos G, Macapinlac HA, Kontoyiannis DP (2008) The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections. Med Mycol 46(1):23-29 (Pubitemid 351298237)
53. Ozsahin H, von Planta M, Muller I, Steinert HC, Nadal D, Lauener R, Tuchschmid P, Willi UV, Ozsahin M, Crompton NE, Seger RA (1998) Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B. Blood 92:2719-2724 (Pubitemid 28469084)
54. Bleeker-Rovers CP, Warris A, Drenth JP, Corstens FH, Oyen WJ, Kullberg BJ (2005) Diagnosis of Candida lung abscesses by 18Ffluorodeoxyglucose positron emission tomography. Clin Microbiol Infect 11:493-495 (Pubitemid 40744397)
55. Win Z, Todd J, Al-Nahhas A (2005) FDG-PET imaging in Pneumocystis carinii pneumonia. Clin Nucl Med 30:690-691 (Pubitemid 41361764)
56. Basu S, Asopa RV, Baghel NS (2009) Early documentation of therapeutic response at 6 weeks following corticosteroid therapy in extensive sarcoidosis: Promise of FDG-PET. Clin Nucl Med 34(10):689-690
57. Jones HA, Marino PS, Shakur BS, Morrell NW (2003) In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma. Eur Respir J 21:567-573 (Pubitemid 36432506)
58. Chen DL, Schuster DP (2004) Positron emission tomography with 18Ffluorodeoxyglucose to evaluate neutrophil kinetics during acute lung injury. Am J Physiol Lung Cell Mol Physiol 286:L834-L840 (Pubitemid 38365070)
59. Jones HA, Clark JC, Minhas PS, Kendall IV, Downey SP, Menon DK (1998) Pulmonary neutrophil activation following head trauma. Am J Respir Crit Care Med 157:A349